Find a Condition by Name
Health & Wellness Information
Find a Doctor by Name
Departments & Divisions
Locations & Maps
Forms & Medical Records
Travel & Lodging
Becoming a Patient
Patient Safety & Care
Health & Wellness Tips
Patient Education & Support
Professional Education - CME/CE
Adult Clinical Trials
Pediatric Clinical Trials
See All Trials
Core Labs & Diagnostics
Tucker Medical Library
Gifts of Assets
Since the introduction of effective chemotherapy, many changes have come about in the management of tuberculosis (TB). Most important have been the shift from sanatoria-based to general hospital and clinic-based treatment and the knowledge that active disease can reliably be prevented among those who are latently infected. With the development of effective drugs for TB, the significant advances in bacteriology, and increased knowledge about the treatment of latent TB infection, the approach to tuberculosis control has become increasingly sophisticated.
The 59th Annual Denver TB Course provides a broad overview of active and latent TB including its epidemiology, transmission, pathogenesis, diagnosis, treatment and management. The purpose of this course is to present this body of knowledge to general internists, epidemiologists, preventative medicine, public health, infectious disease and chest specialists, physician assistants, nurse practitioners, registered nurses and other health care providers who will be responsible for the management and care of patients with tuberculosis.
CLICK HERE to view the agenda.
Epidemiology of tuberculosis
Transmission and pathogenesis
Diagnosis and treatment of tuberculosis including MDR/XDR-TB
Diagnosis and treatment of latent tuberculosis infection
Emphasis on vulnerable populations such as pediatric and HIV co-infection
Contact Investigation Workshop
Discuss the epidemiological features which are associated with increased risk for tuberculosis.
Explain the clinical manifestations of tuberculosis and how they differ in unique patient populations such as pediatrics or HIV co-infection.
Recognize the tools available for diagnosis of tuberculosis and their differences, advantages, and possible shortcomings.
Formulate a treatment regimen for a patient with drug susceptible or drug resistant tuberculosis while understanding the potential toxicities of that regimen.
Discuss the importance and performance of contact investigation among persons exposed to new cases of communicable TB.
$675 Registration Fee
$455 Military, Fellow and Resident*
National Jewish Health Staff - Please contact ProEd@njhealth.org
$550 Registration Fee
$325 Military, Fellow and Resident*
* Verification of Fellowship Status Form (required)
To pay now, please fill out the registration form below. To make payment arrangements, please contact ProEd@njhealth.org.
If you are having problems registering, please call 800.844.2305 or 303.398.1000 or email ProEd@njhealth.org.
Physicians: National Jewish Health is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
National Jewish Health designates this live activity for a maximum of 18.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Registered Nurses: Provider approved by the California Board of Registered Nursing, Provider Number 12724 for 18.0 contact hours.
Registered nurses will receive a separate certificate for each session of the course. You must view the full online session to earn credit; partial credit will not be awarded.